The Claim
Exercise interventions do not significantly alter serum interleukin-6 (IL-6) or C-reactive protein (CRP) levels in older adults with frailty or sarcopenia, with standardized mean differences of -0.04 (95% CI: -0.17 to 0.09, p = 0.52) and -0.08 (95% CI: -0.25 to 0.08, p = 0.32), respectively.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults with frailty or sarcopenia, exercise does not change the levels of interleukin-6 or C-reactive protein in the blood.
See the scientific wording
Exercise interventions do not significantly alter serum interleukin-6 (IL-6) or C-reactive protein (CRP) levels in older adults with frailty or sarcopenia, with standardized mean differences of -0.04 (95% CI: -0.17 to 0.09, p = 0.52) and -0.08 (95% CI: -0.25 to 0.08, p = 0.32), respectively, indicating no consistent anti-inflammatory effect on these downstream markers.
In older adults with muscle loss, aging cells continuously release IL-6, which keeps inflammation high. Exercise reduces muscle damage and lowers TNF-alpha, but it does not stop these aging cells from making IL-6. The liver does not reduce CRP production because IL-6 levels stay high, so CRP stays unchanged.
What the research says
1 studyIn older adults with muscle weakness or frailty, exercise doesn’t reliably lower two common inflammation markers, IL-6 and CRP, even though it does lower another one called TNF-alpha. The study found no meaningful change in IL-6 or CRP after exercise.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.